Bibliografía del artículo
1. Ballantyne JC, Mao J. Opioids for chronic pain. N Engl J Med 2003; 349:1943-53.
2. Gimbel JS, Richards P, Portenoy RK . Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003; 60(6):927-34.
3. Morley JS, Bridson J, Nash TP, Miles JB, White S, Makin MK. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliative Med 2003; 17(7):576-87.
4. Watson CPN, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003; 105:71-8.
5. Hale ME , Dvergsten C, Gimbel J . Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain 2005; 6(1):21-8.
6. Cowan DT, Wilson-Barnett J, Griffiths P, Vaughan DJ, Gondhia A, Allan LG. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine. Pain Med 2005; 6(2):113-21.
7. Kalso E, Edwards J, Moore R, McQuay H. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112:372-80.
8. King T, Gardell LR, Wang R et al. Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain 2005; 116(3):276-88.
9. Xie JY, Herman DS, Stiller CO./Gardell LR, Ossipov M H, Lai J./Porreca F, Vanderah TW . Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci 2005; 25(2):409-16.
10. Lim G, Wang S, Zeng Q, Sung B, Mao J. Evidence for a long-term influence on morphine tolerance after previous morphine exposure: role of neuronal glucocorticoid receptors. Pain 2005; 114(1-2):81-92.
11. Wang S, Lim G, Zeng Q et al. Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci 2004; 24(39):8595-605.
12. Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 2004; 100(4):851-8.
13. Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J Pain Symptom Manage 2003; 26(5):1055-61.
14. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002; 3(5):377-84.
15. Sherburne S, Adler G, Mutter G, Katz N. The effects of long-term opioid therapy on endocrine function in male patients with chronic pain. Submitted.
16. Devereauz PJ, Yusuf S. The evolution of the randomized controlled trial and its role in evidence-based decision making. J Int Med 2003; 254:105-13.
17. Von Korff M, Deyo R A. Potent opioids for chronic musculodkeletal pain: flying blind? Editorial. Pain 2004; 109:207-9.
18. Chabal C, Erjavec MK, Jacobson L et al. Prescription opiate abuse in chronic pain patinets: clinical criteria, incidence and predictors. Clin J Pain 1997; 13:150-5.
19. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain with "problematic" substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage 1998; 16:355-63.
20. Passik SD, Kirsh KL, Whitcomb L et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Therapeut 2004; 26(4):552-61.
21. Adams LL, Gatchel RJ, Robinson RC et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Sympt Manage 2004; 27(5):440-59.
22. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004; 112:65-75.